864 related articles for article (PubMed ID: 25174529)
21. A comparison of particulate hexavalent chromium cytotoxicity and genotoxicity in human and leatherback sea turtle lung cells from a one environmental health perspective.
Speer RM; Wise SS; Croom-Perez TJ; Aboueissa AM; Martin-Bras M; Barandiaran M; Bermúdez E; Wise JP
Toxicol Appl Pharmacol; 2019 Aug; 376():70-81. PubMed ID: 31108106
[TBL] [Abstract][Full Text] [Related]
22. Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water.
Thompson CM; Seiter J; Chappell MA; Tappero RV; Proctor DM; Suh M; Wolf JC; Haws LC; Vitale R; Mittal L; Kirman CR; Hays SM; Harris MA
Toxicol Sci; 2015 Jan; 143(1):16-25. PubMed ID: 25352572
[TBL] [Abstract][Full Text] [Related]
23. Activation of Epidermal Growth Factor Receptor/p38/Hypoxia-inducible Factor-1α Is Pivotal for Angiogenesis and Tumorigenesis of Malignantly Transformed Cells Induced by Hexavalent Chromium.
Kim D; Dai J; Park YH; Fai LY; Wang L; Pratheeshkumar P; Son YO; Kondo K; Xu M; Luo J; Shi X; Zhang Z
J Biol Chem; 2016 Jul; 291(31):16271-81. PubMed ID: 27226640
[TBL] [Abstract][Full Text] [Related]
24. Luteolin inhibits Cr(VI)-induced malignant cell transformation of human lung epithelial cells by targeting ROS mediated multiple cell signaling pathways.
Pratheeshkumar P; Son YO; Divya SP; Roy RV; Hitron JA; Wang L; Kim D; Dai J; Asha P; Zhang Z; Wang Y; Shi X
Toxicol Appl Pharmacol; 2014 Dec; 281(2):230-41. PubMed ID: 25448439
[TBL] [Abstract][Full Text] [Related]
25. Assessment of airborne hexavalent chromium in the home following use of contaminated tapwater.
Finley BL; Kerger BD; Dodge DG; Meyers SM; Richter RO; Paustenbach DJ
J Expo Anal Environ Epidemiol; 1996; 6(2):229-45. PubMed ID: 8792299
[TBL] [Abstract][Full Text] [Related]
26. Particulate and soluble hexavalent chromium are cytotoxic and genotoxic to human lung epithelial cells.
Wise SS; Holmes AL; Wise JP
Mutat Res; 2006 Nov; 610(1-2):2-7. PubMed ID: 16872863
[TBL] [Abstract][Full Text] [Related]
27. Surfactant protein B gene variations and susceptibility to lung cancer in chromate workers.
Ewis AA; Kondo K; Dang F; Nakahori Y; Shinohara Y; Ishikawa M; Baba Y
Am J Ind Med; 2006 May; 49(5):367-73. PubMed ID: 16570259
[TBL] [Abstract][Full Text] [Related]
28. Chromium(VI) enhances (+/-)-anti-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene-induced cytotoxicity and mutagenicity in mammalian cells through its inhibitory effect on nucleotide excision repair.
Hu W; Feng Z; Tang MS
Biochemistry; 2004 Nov; 43(44):14282-9. PubMed ID: 15518579
[TBL] [Abstract][Full Text] [Related]
29. Review of transcriptomic responses to hexavalent chromium exposure in lung cells supports a role of epigenetic mediators in carcinogenesis.
Rager JE; Suh M; Chappell GA; Thompson CM; Proctor DM
Toxicol Lett; 2019 May; 305():40-50. PubMed ID: 30690063
[TBL] [Abstract][Full Text] [Related]
30. [Occupational exposure to chromium(VI) compounds].
Skowroń J; Konieczko K
Med Pr; 2015; 66(3):407-27. PubMed ID: 26325053
[TBL] [Abstract][Full Text] [Related]
31. Continuing exposure to hexavalent chromium, a known lung carcinogen: an analysis of OSHA compliance inspections, 1990-2000.
Lurie P; Wolfe SM
Am J Ind Med; 2002 Nov; 42(5):378-83. PubMed ID: 12382250
[TBL] [Abstract][Full Text] [Related]
32. Hexavalent chromium-induced DNA damage and repair mechanisms.
Wise SS; Holmes AL; Wise JP
Rev Environ Health; 2008; 23(1):39-57. PubMed ID: 18557597
[TBL] [Abstract][Full Text] [Related]
33. Kinetics of an intratracheally administered chromium catalyst in rats.
Vanoirbeek JA; Hoet PH; Nemery B; Verbeken EK; Haufroid V; Lison D; Dinsdale D
J Toxicol Environ Health A; 2003 Feb; 66(4):393-409. PubMed ID: 12554544
[TBL] [Abstract][Full Text] [Related]
34. Time‑order effects of vitamin C on hexavalent chromium‑induced mitochondrial damage and DNA‑protein crosslinks in cultured rat peripheral blood lymphocytes.
Xiao F; Chen D; Luo L; Zhong X; Xie Y; Zou L; Zeng M; Guan L; Zhong C
Mol Med Rep; 2013 Jul; 8(1):53-60. PubMed ID: 23657841
[TBL] [Abstract][Full Text] [Related]
35. Ten factors for considering the mode of action of Cr(VI)-induced gastrointestinal tumors in rodents.
Thompson CM; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2017 Nov; 823():45-57. PubMed ID: 28985946
[TBL] [Abstract][Full Text] [Related]
36. A review of mammalian
Thompson CM; Aardema MJ; Heintz MM; MacGregor JT; Young RR
Crit Rev Toxicol; 2021 Nov; 51(10):820-849. PubMed ID: 35060824
[TBL] [Abstract][Full Text] [Related]
37. Hexavalent chromium exposure activates the non-canonical nuclear factor kappa B pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis.
Wang PS; Liu Z; Sweef O; Saeed AF; Kluz T; Costa M; Shroyer KR; Kondo K; Wang Z; Yang C
Cancer Lett; 2024 May; 589():216827. PubMed ID: 38527692
[TBL] [Abstract][Full Text] [Related]
38. An assessment and quantitative uncertainty analysis of the health risks to workers exposed to chromium contaminated soils.
Paustenbach DJ; Meyer DM; Sheehan PJ; Lau V
Toxicol Ind Health; 1991 May; 7(3):159-96. PubMed ID: 1949057
[TBL] [Abstract][Full Text] [Related]
39. Occupational exposure to hexavalent chromium. Final rule.
Occupational Safety and Health Administration (OSHA), Department of Labor
Fed Regist; 2006 Feb; 71(39):10099-385. PubMed ID: 16528853
[TBL] [Abstract][Full Text] [Related]
40. Inhalation cancer risk assessment of hexavalent chromium based on updated mortality for Painesville chromate production workers.
Proctor DM; Suh M; Mittal L; Hirsch S; Valdes Salgado R; Bartlett C; Van Landingham C; Rohr A; Crump K
J Expo Sci Environ Epidemiol; 2016; 26(2):224-31. PubMed ID: 26669850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
